Parsec Financial Management Inc. maintained its position in Aetna Inc. (NYSE:AET) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,999 shares of the company’s stock at the end of the second quarter. Parsec Financial Management Inc.’s holdings in Aetna were worth $303,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of AET. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Aetna by 31.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 52,641 shares of the company’s stock worth $6,713,000 after buying an additional 12,648 shares during the last quarter. Columbus Circle Investors raised its stake in Aetna by 358.8% in the first quarter. Columbus Circle Investors now owns 51,831 shares of the company’s stock worth $6,611,000 after buying an additional 40,535 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Aetna by 0.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 282,165 shares of the company’s stock worth $35,990,000 after buying an additional 875 shares during the period. Toronto Dominion Bank raised its stake in Aetna by 57.0% in the first quarter. Toronto Dominion Bank now owns 95,608 shares of the company’s stock worth $12,194,000 after buying an additional 34,719 shares during the period. Finally, Boston Advisors LLC raised its stake in Aetna by 20.8% in the first quarter. Boston Advisors LLC now owns 2,906 shares of the company’s stock worth $371,000 after buying an additional 500 shares during the period. 91.69% of the stock is owned by institutional investors and hedge funds.
Aetna Inc. (NYSE:AET) traded down 0.87% during trading on Friday, hitting $154.45. The stock had a trading volume of 1,781,161 shares. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $161.69. The company has a market cap of $51.29 billion, a price-to-earnings ratio of 34.28 and a beta of 0.54. The company has a 50-day moving average price of $154.81 and a 200-day moving average price of $140.38.
Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. The firm had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s quarterly revenue was down 2.7% on a year-over-year basis. During the same period in the previous year, the business posted $2.21 earnings per share. Equities research analysts forecast that Aetna Inc. will post $9.55 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Parsec Financial Management Inc. Continues to Hold Position in Aetna Inc. (NYSE:AET)” was posted by BNB Daily and is the sole property of of BNB Daily. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.baseball-news-blog.com/2017/08/19/parsec-financial-management-inc-maintains-stake-in-aetna-inc-nyseaet-updated.html.
AET has been the topic of several research analyst reports. Royal Bank Of Canada restated a “buy” rating and set a $145.00 target price on shares of Aetna in a research report on Monday, April 24th. Argus restated a “buy” rating and set a $165.00 target price (up previously from $145.00) on shares of Aetna in a research report on Tuesday, May 30th. Cowen and Company set a $170.00 target price on Aetna and gave the company a “buy” rating in a research report on Saturday, May 27th. Credit Suisse Group restated a “buy” rating and set a $155.00 target price on shares of Aetna in a research report on Wednesday, May 17th. Finally, UBS AG reiterated a “buy” rating and issued a $160.00 price target (up previously from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Seven analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Aetna has an average rating of “Buy” and a consensus target price of $157.99.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.